A new blog post

A heading

This is a demo piece of content to test how WordSmith is working. I wonder how to make it work faster… Is it even possible to keep it from automatically making changes? Does the view This is epic. And so smooth I almost didn’t notice. it stopped updating.

Editing my draft works even if it doesn’t live in Astro’s content collections path.

Codonopsis
TLDR

some short stuff

Now updating the renamed note. Link to A New Blog Post about truly amazing things. look at me gooooo. This is epic. And so smooth I almost didn’t notice. it stopped updating. 123

Citations

Nguyen-Ngoc, H., Nguyen, T.-L., Nguyen-Huong, L., Pham, G. N., Pham-Ha-Thanh, T., Nguyen, T.-L., Tran-Thi-Thanh, H., & Nguyen-Thi-Thanh, T. (2026). 2-oxotetrahydroquinoline derivatives from Abelmoschus sagittifolius flowers. Natural Product Research, 1–8. https://doi.org/10.1080/14786419.2026.2683917( Nguyen-Ngoc et al., 2026 )

And a numeric citation: [ Amiri, M., Navabi, J., Shokoohinia, Y., Heydarpour, F., Bahrami, G., Behbood, L., Derakhshandeh, P., Momtaz, S., & Farzaei, M. H. (2019). Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial. Complementary Therapies in Medicine, 45, 262–268. https://doi.org/10.1016/j.ctim.2019.05.001 2 ]

And with groups [ Cui, J., Eneroth, P., & Bruhn, J. G. (1999). Gynostemma pentaphyllum: identification of major sapogenins and differentiation from Panax species. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 8(3), 187–191. https://doi.org/10.1016/s0928-0987(99)00013-5 3 , Dandan, Y., Jingting, Z., Minzhe, W., Zhuoyue, C., & Xinyun, L. (2025). The Therapeutic Effects of Acorus Tatarinowii Volatile Oil and Electroacupuncture in Post-Stroke Cognitive Impairment Patients: A Clinical Trial Protocol. Brain and Behavior, 15(7), e70631. https://doi.org/10.1002/brb3.70631 4 ]

Testing real-time changes for events emmited by obsidian.

Let’s see how the live preview does with a constant stream of input. Like if I was to really write something Cui, J., Eneroth, P., & Bruhn, J. G. (1999). Gynostemma pentaphyllum: identification of major sapogenins and differentiation from Panax species. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 8(3), 187–191. https://doi.org/10.1016/s0928-0987(99)00013-5( Cui et al., 1999 ). Is the image still visible? Are transclusions going to work? Are they? Neah. Or will they? Will they?!

Trease and Evans Pharmacognosy

Description

This encyclopedic reference work on pharmacognosy covers the study of those natural substances, principally plants, that find a use in medicine. Its popularity and longevity stem from the book’s balance between classical (crude and powdered drugs’ characterization and examination) and modern (phytochemistry and pharmacology) aspects of this branch of science, as well as the editor’s recognition in recent years of the growing importance of complementary medicines, including herbal, homeopathic and aromatherapy. No other book provides such a wealth of detail. A reservoir of knowledge in a field where there is a resurgence of interest - plants as a source of drugs are of growing interest both in complementary medicine fields and in the pharmaceutical industry in their search for new ‘lead compounds’. Dr Evans has been associated with the book for over 20 years and is a recognised authority in all parts of the world where pharmacognosy is studied, his knowledge and grasp of the subject matter is unique. Meticulously referenced and kept up to date by the editor, new contributors brought in to cover new areas. New chapter on ‘Neuroceuticals’. Addition of many new compounds recently added to British Pharmacopoeia as a result of European harmonisation. Considers development in legal control and standardisation of plant materials previously regarded as ‘herbal medicines’. More on the study of safety and efficacy of Chinese and Asian drugs. Quality control issues updated in line with latest guidelines (BP 2007).

Chapter 1 - Plants in medicine: the origins of pharmacognosy

  • Western medicine has origins in Mesopotamia and Egypt
  • the Unani (Islamic) and Ayurvedic (Hindu) systems are centered in western Asia and the Indian subcontinent
  • the Chinese, Japanese, and others in the Orient.
Quote

How and when such medicinal plants were first used is, in many cases, lost in pre-history, indeed animals, other than man, appear to have their own materia medica. [p. 3]

  • following oral transmission of medical information, came the use of writing, and some of the oldest herbal medicine “documents”:
    • the Egyptian Papyrus Ebers c. 1600 BC
    • baked clay tablets - some 600 cuneiform tablets c. 650 BC from Ashurbanipal’s library at Nineveh (can be seen at the British Museum) refer to drugs used today.
    • Chinese medicinal plants have been documented in texts from the 4th century BC
    • Ayurvedic medicine (Ayurveda 2500-600 BC)
    • Unani medicine - Kitab-Al-Shifa, the magnum opus of Avicenna 980-1037 AD.
  • they were followed by 1440 AD and onwards parchments, manuscripts, pharmacopoeias, printed herbals, and so forth.
  • a great wealth of knowledge in tribal societies is still transmitted orally across generations in the tribal societies of tropical Africa, North and South America, and the Pacific countries.
  • These areas of the world contain the world’s largest number of plant species, not found elsewhere. With the westernization of many of the peoples of these zones there is a danger of losing local knowledge. [p. 3]
  • Furthermore, there is an alarming rate of plant species extermination in certain regions, even before there’s been a chance to record them, much less study their medicinal properties and constituents. There must be increased efforts towards the conservation of plant gene pools, as well as responsible harvesting or controlled cultivation of such plants specifically for medicine production.[p. 3]
  • when plant-derived medicine becomes popular, there is a risk of extinction for the species of interest. Historical examples include anticancer drugs such as those derived from Taxus, Podophyllum, and Ochrosia spp. Local wild sources can soon become exhausted - such as it happened with Catharanthus roseus, Coleus forskohlii, Gingko biloba, Arnica montana, and Taxus brevifolia. The native source of Leucojum aestivum was endangered due to the demand for the drug galanthamine used in the treatment of Alzheimer’s disease [p. 4].

Chapter 2 - The scope and practice of pharmacognosy

  • until recently, pharmacognosy was regarded as a subject in the pharmaceutical curriculum focused on natural products employed in allopathic contemporary conventional medicine.
Note to self

Avoid using “allopathic” - it used to be a derogatory term used by homeopaths against “heroic medicine”, a system of medicine used in Europe in the early 1800s that did not rely on evidence of effectiveness (“gallenic”) - see Allopathic medicine. While the term is used in certain regions to distinguish conventional medicine from traditional, alternative, or complementary systems, it is absolutely not a fair descriptor for modern conventional medicine.

  • many crude drugs used in traditional systems of medicine are well studied today using chromatographic, chemical and physical tests, and in some cases clinical trials.
  • the marketing efforts for and incresing demand for Chinese and other Asian traditional medicines stimulate further research as there is a need for quality controls.
Further research

See the British Pharmacopoeia list of medicinal plants.

  • pharmacognosy, despite primarily focusing on plant material, can also cover a small number of animal products that are traditionally used across the world such as beeswax, gelatin, woolfat, vitamins, as well as marine organisms, both plant and animal, natural fibers, flavoring and suspending agents, colorants, disintegrants, stabilizers, filtering and support media.
  • related areas with natural associations with pharmacognosy are poisonous and hallucinogenic organisms, allergens, herbicides, insecticides, and molluscicides.

Arranging drugs for study

  • alphabetical by Latin of vernacular names - dictionaries, pharmacopoeias, suitable for quick reference but does not provide indications of inter-relationships between drugs.
  • taxonomic - on the basis on an accepted system of botanical classification - drugs are arranged according to plants from which they are obtained in classes, orders, families, genera and species. It allows for precise and ordered arrangement, reducing ambiguity. Becoming less popular for teaching purposes as learners tend to forget botanical knowledge.
  • morphological - drugs are divided into groups such as:
    • organized drugs: leaves, flowers, fruits, seeds, herbs and entire organisms, woords, barks, rhizomes and roots.
    • unorganized drugs: dried latices, extracts, gums, resins, oils, fats, waxes.
    • the groupings are helpful for the practical study of crude drugs.
  • pharmacological or therapeutic - based on the action of the drug’s most important constituents or their therapeutic use. While popular since 1956, this method is not perfect, as the constituents of any one drug may fall into different pharmacological groups.
  • chemical or biogenetic - the important constituents such as alkaloids, glycosides, volatile oils, or their biosynthetic pathways form the basis of the classification.
    • a popular approach but phytochemically biased
    • ambiguous when some drugs possess a number of active principles belonging to different phytochemical groups - such as liquorice, ginseng, valerian.
  • provides list of books and or “libraries” by type.

Resources

Monographs to collect or consult
  • German Commission E Monographs and their expanded edition, as translated by the American Botanical Coundil.
  • European Scientific Cooperative for Phytotherapy (ESCOP) monographs
  • Americal Herbal Pharmacopoeia (AHP) monographs
  • World Heath Organization (WHO) monographs
  • United States Pharmacopoeia (USP) monographs
Journals to focus on
  • Planta Medica
  • Journal of Ethnopharmacology
  • Phytochemistry
  • Journal of Natural Products
  • Natural Products Research
  • Natural Products Sciences
  • Natural Product Reports
  • Alkaloids
  • Abstracts of Chinese Medicine
Books such as Medicinal and Aromatic Plants – Industrial Profiles
Dictionaries
  • Dictionary of Organic Compounds
  • Dictionary of Alkaloids
  • Dictionary of Terpenoids
  • Dictionary of Natural Products
  • Phytochemical Dictionary: A Handbook of Bioactive Compounds from Plants

Chapter 3 - Plant nomenclature and taxonomy

References

Export
[1]
Nguyen-Ngoc, H., Nguyen, T. L., Nguyen-Huong, L., Pham, G. N., Pham-Ha-Thanh, T., Nguyen, T. L., Tran-Thi-Thanh, H., & Nguyen-Thi-Thanh, T. (2026). 2-oxotetrahydroquinoline derivatives from Abelmoschus sagittifolius flowers. Natural Product Research, 1-8.https://europepmc.org/article/MED/42287729
[2]
Amiri, M., Navabi, J., Shokoohinia, Y., Heydarpour, F., Bahrami, G., Behbood, L., Derakhshandeh, P., Momtaz, S., & Farzaei, M. H. (2019). Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial. Complementary Therapies in Medicine, 45, 262-268.https://europepmc.org/article/MED/31331572
[3]
Cui, J., Eneroth, P., & Bruhn, J. G. (1999). Gynostemma pentaphyllum: identification of major sapogenins and differentiation from Panax species. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 8(3), 187-191.https://europepmc.org/article/MED/10379041
[4]
Dandan, Y., Jingting, Z., Minzhe, W., Zhuoyue, C., & Xinyun, L. (2025). The Therapeutic Effects of Acorus Tatarinowii Volatile Oil and Electroacupuncture in Post-Stroke Cognitive Impairment Patients: A Clinical Trial Protocol. Brain and Behavior, 15(7), e70631.https://europepmc.org/article/PMC/12224042